BioLineRx Ltd.
BLRX · NASDAQ
11/24/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4,943 | $304 | $255 | $11,749 |
| % Growth | 1,526% | 19.2% | -97.8% | – |
| Cost of Goods Sold | -$822 | $72 | $34 | $6,089 |
| Gross Profit | $4,121 | $232 | $221 | $5,660 |
| % Margin | 83.4% | 76.3% | 86.7% | 48.2% |
| R&D Expenses | -$2,565 | $2,326 | $1,623 | $1,865 |
| G&A Expenses | $0 | $209 | $989 | $14,055 |
| SG&A Expenses | -$1,390 | $209 | $989 | $5,825 |
| Sales & Mktg Exp. | -$5,553 | $0 | $0 | -$8,230 |
| Other Operating Expenses | $0 | $0 | $0 | $2,396 |
| Operating Expenses | -$7,953 | $2,535 | $2,612 | $10,086 |
| Operating Income | $0 | -$2,303 | -$2,391 | -$4,426 |
| % Margin | 0% | -757.6% | -937.6% | -37.7% |
| Other Income/Exp. Net | $756 | -$1,637 | $7,518 | $1,239 |
| Pre-Tax Income | $0 | -$3,940 | $5,127 | -$3,187 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,822 | -$3,940 | $5,127 | -$3,187 |
| % Margin | -117.8% | -1,296.1% | 2,010.6% | -27.1% |
| EPS | -1.47 | -1 | 0.065 | -0.041 |
| % Growth | -47% | -1,650.4% | 259.3% | – |
| EPS Diluted | -1.47 | -1 | 0.065 | -0.041 |
| Weighted Avg Shares Out | 3,949 | 3,949 | 79,856 | 79,856 |
| Weighted Avg Shares Out Dil | 3,949 | 3,949 | 79,856 | 79,856 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $490 | $294 | $286 |
| Interest Expense | $0 | $276 | $420 | $4,435 |
| Depreciation & Amortization | $0 | $176 | $165 | $1,852 |
| EBITDA | $0 | -$3,488 | $5,712 | $3,100 |
| % Margin | 0% | -1,147.4% | 2,240% | 26.4% |